Insider Trading Activity - BIOS Fund II NT LP

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for BIOS Fund II NT LP

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-08-14 Sale(A)	2024-08-20 8:45 pm	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	24,999	$8	$199,992	131,248 (Indirect)	View
2024-08-14 Purchase	2024-08-14 8:44 pm	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	500,000	$8	$4,000,000	216,083 (Indirect)	View
2024-08-14 Sale	2024-08-14 8:44 pm	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	24,999	$9	$224,991	216,083 (Indirect)	View
2024-05-23 Sale	2024-05-28 4:30 pm	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	30,000	$6.3033	$189,100	747,049 (Indirect)	View
2024-02-27 Sale	2024-02-29 9:54 pm	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	144,000	$4.6965	$676,294	753,428 (Indirect)	View
2024-01-17 Sale	2024-01-19 4:31 pm	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	58,889	$4.2	$247,334	784,013 (Indirect)	View
2023-11-29 Sale	2023-12-01 06:01 am	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	145,348	$3.44	$499,997	1,170,117 (Indirect)	View
2023-06-21 Purchase	2023-06-23 9:38 pm	Azitra Inc	AZTR	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	2,297,490	$1.3058	$3,000,000	527,195 (Indirect)	View
2022-12-12 Purchase	2022-12-13 07:00 am	IN8BIO INC.	INAB	Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC Director 10% Owner	75,001	$2.4788	$185,912	4,270,424 (Indirect)	View
2022-11-28 Purchase	2022-11-29 07:00 am	COGNITION THERAPEUTICS INC	CGTX	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Director 10% Owner	16,064	$2.6497	$42,565	3,151,266 (Indirect)	View
2022-11-16 Purchase	2022-11-17 07:00 am	COGNITION THERAPEUTICS INC	CGTX	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Director	71,000	$1.4	$99,400	3,149,395 (Indirect)	View
2022-11-15 Purchase	2022-11-16 06:59 am	COGNITION THERAPEUTICS INC	CGTX	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Director	1,500,000	$1.2	$1,800,000	3,141,126 (Indirect)	View
2022-11-08 Sale	2022-11-09 9:37 pm	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	350,000	$4.4	$1,540,000	190,230 (Indirect)	View
2022-09-28 Purchase	2022-09-29 06:14 am	IN8BIO INC.	INAB	Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Capital Management LP BIOS Advisors GP LLC Director 10% Owner	25,000	$2.0214	$50,535	4,261,689 (Indirect)	View
2022-09-02 Sale	2022-09-07 4:55 pm	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	6,445	$5.2	$33,514	1,889,456 (Indirect)	View
2022-08-26 Purchase	2022-08-30 1:16 pm	IN8BIO INC.	INAB	Fletcher Aaron G.L. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner	51,214	$2.0178	$103,340	4,258,776 (Indirect)	View
2022-08-26 Purchase	2022-08-30 08:10 am	IN8BIO INC.	INAB	Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner	51,214	$2.0178	$103,340	4,258,776 (Indirect)	View
2022-08-17 Purchase	2022-08-18 8:00 pm	IN8BIO INC.	INAB	Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner	50,000	$1.93	$96,500	4,252,810 (Indirect)	View
2022-08-16 Purchase	2022-08-17 10:27 am	IN8BIO INC.	INAB	Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund III QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC Director 10% Owner	1,773,684	$1.9	$3,370,000	4,348,150 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-10-04 Disposition	2024-10-11 6:12 pm	2023-12-13 2025-06-13	IN8BIO INC.	INAB	Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP Bios Clinical Opportunity Fund LP Bios Equity COF LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	574,241	$0	11,862,579 (Indirect)	View
2024-10-04 Option Award	2024-10-11 6:12 pm	2023-12-13 2025-10-04	IN8BIO INC.	INAB	Fletcher Aaron G.L. BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Incysus Co-Invest I LP Bios Clinical Opportunity Fund LP Bios Equity COF LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	574,241	$0	11,862,579 (Indirect)	View
2024-08-14 Exercise	2024-08-14 8:44 pm	N/A N/A	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	37,951	$5.27	216,083 (Indirect)	View
2024-08-14 Exercise	2024-08-14 8:44 pm	N/A N/A	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	37,951	$0	216,083 (Indirect)	View
2024-08-14 Conversion	2024-08-14 8:44 pm	N/A N/A	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	9,380,699	$0	216,083 (Indirect)	View
2024-08-12 Option Award	2024-08-14 8:44 pm	N/A 2034-08-12	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	15,000	$0	216,083 (Indirect)	View
Ownership	2024-08-12 6:29 pm	N/A N/A	ACTUATE THERAPEUTICS INC.	ACTU	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	0	$0	8,835,435 (Indirect)	View
2024-06-07 Option Award	2024-06-11 9:33 pm	N/A 2034-06-07	COGNITION THERAPEUTICS INC	CGTX	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BP Directors LP Director 10% Owner	8,500	$0	6,023,000 (Indirect)	View
2024-01-17 Exercise	2024-01-19 4:31 pm	N/A N/A	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	79,021	$3.13	784,013 (Indirect)	View
2024-01-17 Exercise	2024-01-19 4:31 pm	2019-03-07 2024-03-07	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	79,021	$0	784,013 (Indirect)	View
2023-11-08 Option Award	2023-11-13 09:48 am	N/A N/A	COGNITION THERAPEUTICS INC	CGTX	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BP Directors LP Director 10% Owner	500,095	$1.05	6,012,000 (Indirect)	View
2023-06-21 Conversion	2023-06-23 9:38 pm	N/A N/A	Azitra Inc	AZTR	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	6,807,032	$0	527,195 (Indirect)	View
Ownership	2023-06-15 5:55 pm	N/A N/A	Azitra Inc	AZTR	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner	0	$0	4,535,218 (Indirect)	View
2023-06-09 Option Award	2023-06-13 8:02 pm	N/A 2033-06-09	COGNITION THERAPEUTICS INC	CGTX	Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Equity Partners III LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP Director 10% Owner	6,000	$0	5,511,905 (Indirect)	View
2022-09-02 Exercise	2022-09-07 4:55 pm	N/A N/A	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	32,538	$1.03	1,889,456 (Indirect)	View
2022-09-02 Exercise	2022-09-07 4:55 pm	2018-12-17 2028-12-16	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	32,538	$0	1,889,456 (Indirect)	View
2021-10-13 Conversion(A)	2022-02-01 7:24 pm	N/A N/A	COGNITION THERAPEUTICS INC	CGTX	BIOS Memory SPV I LP BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP 10% Owner	1,424,014	$0	1,424,014 (Direct)	View
Ownership(A)	2022-02-01 6:44 pm	N/A N/A	COGNITION THERAPEUTICS INC	CGTX	BIOS Memory SPV I LP BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP BIOS Memory SPV II LP BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP 10% Owner	0	$0	1,424,014 (Direct)	View
2021-08-03 Conversion	2021-08-03 4:57 pm	N/A N/A	IN8BIO INC.	INAB	Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC 10% Owner	12,649,578	$0	359,374 (Indirect)	View
Ownership	2021-07-29 9:36 pm	N/A N/A	IN8BIO INC.	INAB	Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC 10% Owner	0	$0	6,625,102 (Indirect)	View
2020-06-15 Other	2020-06-16 7:30 pm	N/A 2030-06-14	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	9,135	$0	98,657 (Indirect)	View
2020-06-15 Conversion	2020-06-16 7:30 pm	N/A N/A	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	2,293,804	$0	98,657 (Indirect)	View
Ownership	2020-06-10 8:23 pm	N/A N/A	Lantern Pharma Inc.	LTRN	Fletcher Aaron G.L. BIOS Fund I LP BIOS Fund I QP LP BIOS Fund II LP BIOS Fund II QP LP BIOS Fund II NT LP Bios Equity Partners LP Bios Equity Partners II LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner	0	$0	1,968,478 (Indirect)	View

(A) Indicate amendment filing.

Insider Trading & Ownership - BIOS Fund II NT LP